170798 ⎘
Detection or diagnosis of diseases Endocrine or metabolic disorders
RISK ANALYSIS IN PATIENTS WITH AND WITHOUT METABOLIC SYNDROME
#302Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
#303DIAGNOSTIC METHOD OF MUCOPOLYSACCHARIDOSES
#304USE OF ENTEROVIRUS FOR DIAGNOSTICS, TREATMENT AND PREVENTION OF DISEASE
#305Methods for Detecting Metabolic States by Laser Ablation Electrospray Ionization Mass Spectrometry
#306COMPOSITION FOR IMPROVING LIVER METABOLISM AND DIAGNOSTIC METHOD
#307Methods and compositions for multiplexed screening of disease
#308Method for diagnosing the metabolic syndrome (MS)
#309METHODS OF ANALYSIS AND DETECTING MOLECULAR DEFECTS IN TRANSCOBALAMIN I DEFICIENCY
#310Methods for assaying alpha-L-iduronidase enzymatic activity
#311LYSINE ACETYLATION SITES
#312COMPOSITIONS AND MULTIPLEX ASSAYS FOR MEASURING BIOLOGICAL MEDIATORS OF PHYSIOLOGICAL HEALTH
#313INTERLEUKIN 6 AND TUMOR NECROSIS FACTOR ALPHA AS BIOMARKERS OF JNK INHIBITION
#314Method of evaluating visceral fat accumulation, visceral fat accumulation-evaluating apparatus, visceral fat accumulation-evaluating method, visceral fat accumulation-evaluating system, visceral fat accumulation-evaluating program, recording medium, and method of searching for prophylactic/ameliorating substance for visceral fat accumulation
#315Mass spectrometry assay for congenital adrenal hyperplasia
#316Method for predicting cancer and other diseases
#317Autophagy and phospholipidosis pathway assays
#318METHODS TO DECREASE THE RISK OF METABOLIC SYNDROME POST IMMUNIZATION
#319Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#320DIAGNOSTIC MARKER FOR FABRY DISEASE
#321IRON-REGULATING PROTEIN-2(IRP-2) AS A DIAGNOSTIC FOR NEURODEGENERATIVE DISEASE
#322SCREENING METHOD FOR ANTI-DIABETIC COMPOUNDS
#323Impaired Alleles of Genes Involved in Metabolic Pathways and Methods for Detecting and Using the Same
#324Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency
#325Compositions and Methods for Modulating mTOR Signaling
#326Electronic methods for the detection of analytes
#327Metabolic Syndrome Genetics
#328Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#329Electronic methods for the detection of analytes
#330Biological markers for longevity and diseases and uses thereof
#331Method for determining insulin sensitivity with biomarkers
#332Simultaneous detection of metabolic enzyme activity and metabolite levels
#333Mitochondrial DNA variants associated with metabolic syndrome
#334AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE
#335Immunochemical determination method and determination reagent for cytochrome c
#336Substrates and internal standards for mass spectrometry detection
#337PDE11A mutations in adrenal disease
#338Detecting succinylacetone
#339Detecting isomers using differential derivatization mass spectrometry
#340G PROTEIN COUPLED RECEPTORS AND USES THEREOF
#341Intestinal folate transporter method
#342Electronic methods for the detection of analytes
#343Compositions and Methods for Treating Disorders Associated with Abnormal Phosphate Metabolism
#344ASSAYS FOR DETECTING NATIVE-STATE PROTEINS AND IDENTIFYING COMPOUNDS THAT MODULATE THE STABILITY OF NATIVE-STATE PROTEINS
#345Use of a Dg147 Protein Product for Preventing and Treating Metabolic Disorders
#346Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency comprising administration of IGF-1 and growth hormone
#347Assays for diagnosing and evaluating treatment options for Fabry disease
#348IRON REGULATING PROTEIN-2 (IRP-2) AS A DIAGNOSTIC FOR NEURODEGENERATIVE DISEASE
#349Identifying risk of a medical event
#350CMKLR regulation of adipogenesis and adipocyte metabolic function
#351Device and method for analysis of a metabolic malady
#352Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention
#353Human Obesity Susceptibility Gene and Uses Thereof
#354Diagnostic markers for sub-acute ruminal acidosis
#355Categorically ranking animals for feed efficiency
#356METHODS AND COMPOSITIONS FOR DETECTING ENZYMATIC ACTIVITY
#357DIAGNOSTIC METHOD OF MUCOPOLYSACCHARIDOSES
#358Time-resolved non-invasive optometric device for medical diagnostic
#359Method of diagnosing autoimmune polyglandular syndrome and kits thereof
#360Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same
#361Computer systems and methods for inferring casuality from cellular constituent abundance data
#362Identification of adiponutrin-related proteins as esterases and methods of use for the same
#363Simultaneous detection of metabolic enzyme activity and metabolite levels
#364Computer systems and methods for inferring causality from cellullar constituent abundance data
#365Use of dg153 secreted protein products for preventing and treating pancreatic disease and/or obesity and/or metabolic syndrome
#366Mass spectrometry methods for simultaneous detection of metabolic enzyme activity and metabolite levels
#367Calcium receptor-active molecules
#368G protein-coupled receptors
#369Non-human animal models for diabetic complications and their uses
#370Systems and methods for measuring sodium concentration in saliva
#371Biological markers for longevity and diseases and uses thereof
#372Use of Mrf-2 for screening and therapies
#373Antibodies to iron regulating protein -2 (IRP-2) as a diagnostic for neurodegenerative disease
#374Compositions and methods for treating disorders associated with abnormal phosphate metabolism
#375Method for determining concentration; a dialyser
#376DMBT1 as a clinical marker and uses thereof
#377Novel receptors
#378Methods of using fluorescent pH indicators for intracellular assays
#379Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency
#380Tandem mass spectrometry method for the genetic screening of inborn errors of metabolism in newborns
#381Methods for diagnosing and treatment of hyperphosphatemic conditions using FGF20 polypeptides
#382Determining mucopolysaccharidoses and decision support tool